Updates and news related to prostate cancer:
Prostate Cancer Risk Prediction Algorithm Could Help Target Testing for Men at Greatest Risk
Cambridge scientists have created a comprehensive tool for predicting an individual's risk of developing prostate cancer.
FDA Grant Clearance to AI-Powered Prostate Cancer Management Platform
The FDA has granted 510(k) clearance to iQuest.
From the Prostate Cancer Research Desk
Clinical trials of new therapies
Novel PSMA-TRT-based Triplet Regimen Appears Effective in Prostate Cancer
All patients with chemo-naïve metastatic castration-resistant prostate cancer experienced PSA decline, and half the cohort experienced a PSA decline greater than 50% after treatment with a novel PSMA-targeted radionuclide therapy.
Increased Risk with Use of Docetaxel
The risk for febrile neutropenia from second-line docetaxel (Taxotere) is high in patients with metastatic castration-resistant prostate cancer, particularly for men older than age 75 years and those with multiple comorbidities.
Active Surveillance, Exercise, Vegan Diets, and Healthy Fats
The Prostate Cancer Foundation answers your questions!
Awareness, Usage of Prostate Cancer Genetic Testing Are Low vs Other Cancers
How are patients getting information about cancer genetic testing?
Concurrent/Adjuvant ADT Sequencing Appears Optimal in Patients Receiving Prostate-Only Radiotherapy
Androgen deprivation therapy (ADT) sequenced during and after radiotherapy (RT) has clinical benefits for patients undergoing treatment for prostate cancer.
Reasons to Rename Gleason 6 Prostate Cancer to Non-Cancer
A leading proponent explains the arguments.
Diet and Prostate Cancer
What affect do eggs, dairy, and supplements have on prostate cancer?